Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002.
- Citation:
- J Thorac Oncol vol 2 (7) 645-51
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 798
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- CA31946, CA33601
- Corr. Author:
- Authors:
- Antonius A Miller Xiaofei F Wang Jeffrey A Bogart Lydia D Hodgson Caio M S Rocha Lima James E Radford Everett E Vokes Mark R Green
- Networks:
- Study
- CALGB-30002
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Small Cell, Combined Modality Therapy, Dose-Response Relationship, Drug, Etoposide, Female, Follow-Up Studies, Humans, Lung Neoplasms, Male, Middle Aged, Paclitaxel, Retrospective Studies, Severity of Illness Index, Survival Rate, Topotecan, Treatment Outcome